Ondansetron

VOMIVIB

COMPOSITION
Ondansetron2MG/ML
SPECIFICATION
FORMINJECTABLE
PACKING 10’s
PACKING TYPE
MRP106

DESCRIPTION

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. [PubChem]

SIDE EFFECTS

Low blood pressure and fainting, sudden blindness, severe constipation

INDICATION

For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, postoperation, and radiation. Also used for the treatment of postoperative nausea and vomiting.